申请人:Universidad Complutense De Madrid
公开号:US05716963A1
公开(公告)日:1998-02-10
Said derivatives have the general formula (I) and are: ##STR1## (I-A) 4,6,7-trimethyl-5,8,8a,10a-tetrahydro-1H-1-azaanthracen-2,9,10-trione; (I-B) 2-ethoxy-3-methyl-1-azaanthracen-9,10-dione; (I-C) 3-ethyl-1,8-dihydro-1H-1,8-diazaanthracen-2,7,9,10-tetraone; (I-d) 2-acethoxy-3-methyl-1,8-diazaanthracen-2,9,10-trione; (I-e) 6-fluor-4-methyl-1H-1,8-diazaanthracen-2,9,10-trione; (I-f) 6-dimethylamino-4-methyl-1H-1,8-diazaanthracen-2,9,10-trione; (I-g) 4-methyl-5-(2-nitrophenyl)-5,8-dihydro-1H-1,8-diazaanthracen-2,9,10-trione ; (I-h) 3,5-dimethyl-1,8-dihydro-1,8-diazaanthracen-2,7,9,10-tetraone; (I-i) 3,6-difluor-1,8-diazaanthracen-9,10-dione; (I-j) 6-methyl-3-phenyl-1H-1,8-diazaanthracen-2,9,10-trione; (I-k) 3-fluor-4-methyl-1-dihydro-1-azaanthracen-9,10-dione; 3-fluor-1-azaanthracen-1,10-dione. Application as antitumor agents.
所述衍生物具有通式(I),即:4,6,7-三甲基-5,8,8a,10a-四氢-1H-1-氮杂蒽-2,9,10-三酮(I-A);2-乙氧基-3-甲基-1-氮杂蒽-9,10-二酮(I-B);3-乙基-1,8-二氢-1H-1,8-二氮杂蒽-2,7,9,10-四酮(I-C);2-乙酰氧基-3-甲基-1,8-二氮杂蒽-2,9,10-三酮(I-d);6-氟-4-甲基-1H-1,8-二氮杂蒽-2,9,10-三酮(I-e);6-二甲胺基-4-甲基-1H-1,8-二氮杂蒽-2,9,10-三酮(I-f);4-甲基-5-(2-硝基苯基)-5,8-二氢-1H-1,8-二氮杂蒽-2,9,10-三酮(I-g);3,5-二甲基-1,8-二氢-1,8-二氮杂蒽-2,7,9,10-四酮(I-h);3,6-二氟-1,8-二氮杂蒽-9,10-二酮(I-i);6-甲基-3-苯基-1H-1,8-二氮杂蒽-2,9,10-三酮(I-j);3-氟-4-甲基-1-二氢-1-氮杂蒽-9,10-二酮(I-k);3-氟-1-氮杂蒽-1,10-二酮。用作抗肿瘤剂。